1. Home
  2. PRTA vs FMAO Comparison

PRTA vs FMAO Comparison

Compare PRTA & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • FMAO
  • Stock Information
  • Founded
  • PRTA 2012
  • FMAO 1897
  • Country
  • PRTA Ireland
  • FMAO United States
  • Employees
  • PRTA N/A
  • FMAO N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • FMAO Savings Institutions
  • Sector
  • PRTA Health Care
  • FMAO Finance
  • Exchange
  • PRTA Nasdaq
  • FMAO Nasdaq
  • Market Cap
  • PRTA 472.1M
  • FMAO 356.9M
  • IPO Year
  • PRTA N/A
  • FMAO N/A
  • Fundamental
  • Price
  • PRTA $8.20
  • FMAO $26.13
  • Analyst Decision
  • PRTA Buy
  • FMAO
  • Analyst Count
  • PRTA 10
  • FMAO 0
  • Target Price
  • PRTA $14.86
  • FMAO N/A
  • AVG Volume (30 Days)
  • PRTA 1.2M
  • FMAO 21.8K
  • Earning Date
  • PRTA 08-04-2025
  • FMAO 10-29-2025
  • Dividend Yield
  • PRTA N/A
  • FMAO 3.34%
  • EPS Growth
  • PRTA N/A
  • FMAO 38.39
  • EPS
  • PRTA N/A
  • FMAO 2.16
  • Revenue
  • PRTA $10,341,000.00
  • FMAO $108,632,000.00
  • Revenue This Year
  • PRTA N/A
  • FMAO $1.60
  • Revenue Next Year
  • PRTA $389.77
  • FMAO $13.77
  • P/E Ratio
  • PRTA N/A
  • FMAO $12.26
  • Revenue Growth
  • PRTA N/A
  • FMAO 13.86
  • 52 Week Low
  • PRTA $4.32
  • FMAO $20.88
  • 52 Week High
  • PRTA $22.83
  • FMAO $34.15
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.73
  • FMAO 58.09
  • Support Level
  • PRTA $8.05
  • FMAO $24.60
  • Resistance Level
  • PRTA $8.73
  • FMAO $27.01
  • Average True Range (ATR)
  • PRTA 0.38
  • FMAO 0.81
  • MACD
  • PRTA -0.05
  • FMAO 0.23
  • Stochastic Oscillator
  • PRTA 47.62
  • FMAO 89.44

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About FMAO Farmers & Merchants Bancorp Inc.

Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.

Share on Social Networks: